Biological Dynamics CEO, Raj Krishnan, Phd, introduced "Quantification of Circulating Biomarkers from Plasma and Serum Using AC Electrokinetic" presentation at the 7th Annual Next Generation Diagnostics Summit at Washington, DC.
Read MoreSAN DIEGO, Calif., January 6, 2015 -- Biological Dynamics, Inc. today announced that Raj Krishnan, PhD and David Charlot, PhD, President and CTO, will present at this annual investor and partnering conference on Monday, January, 12, 2015 in San Francisco, CA.
Read MoreBiological Dynamics is a private molecular diagnostics company located in San Diego. Our proprietary technology offers a novel, fast, and cost-effective lab-on-chip ACE platform that isolates nanoparticles from high conductance physiological solutions.
Our product, the TR(ACE)™ assay, will utilize the platform for monitoring treatment response in oncology. TR(ACE)™ has not been cleared or approved by the U.S. FDA or any foreign regulatory agency.
